Management of Elevated C-Reactive Protein

Immediate Assessment and Evaluation

When CRP is elevated, immediately repeat the test in 2 weeks while simultaneously evaluating for infection, inflammation, or tissue injury based on the magnitude of elevation and clinical context 1
Examine the patient for sources of infection or inflammation and measure body temperature for CRP ≥10 mg/L 1
Obtain blood cultures if infection is suspected, particularly if fever, tachycardia, or hemodynamic compromise is present 2
Check complete blood count for leukocytosis, left-shift, or neutropenia 3
Assess liver function tests (AST/ALT) to exclude hepatic inflammation or fatty liver disease 2, 3

The median CRP values differ significantly by condition: acute bacterial infections ~120 mg/L, inflammatory diseases ~65 mg/L, solid tumors ~46 mg/L, non-bacterial infections ~32 mg/L, and stable cardiovascular disease ~6 mg/L 1, 3
CRP >10 mg/L persists, discard the initial result and search for obvious infection/inflammation 4
Average two CRP measurements taken 2 weeks apart for stable assessment 4, 2

Screen for respiratory, abdominal, urinary tract, soft tissue, and bloodstream infection sources 3
Document recent trauma, surgery, or known inflammatory conditions 2
Assess for fever, dyspnea, tachypnea, and focal chest signs if respiratory symptoms present 5
Consider procalcitonin if available to help differentiate bacterial infection 3

Categorize CRP for cardiovascular risk assessment: low risk <1.0 mg/L, average risk 1.0-3.0 mg/L, high risk >3.0 mg/L 4, 1, 2
For patients with intermediate cardiovascular risk, elevated CRP may reclassify them to high risk, potentially indicating need for statin therapy 1
CRP >5 mg/L in symptomatic patients with inflammatory bowel disease suggests active endoscopic inflammation requiring treatment adjustment 2
Use CRP in combination with symptoms to guide treatment decisions in inflammatory bowel disease (sensitivity 67%, specificity 77% for moderate-to-severe endoscopic activity) 2

Identify and treat the specific underlying infection or inflammatory condition 1
Repeat CRP testing after clinical recovery to confirm normalization 1
In patients with inflammatory conditions achieving symptomatic remission, repeat CRP measurement in 3-6 months 1
CRP normalizes more quickly than ESR during resolution of inflammation 1, 2
Serial measurements are more valuable than single values for diagnosis and monitoring treatment response 3

Approximately 20% of smokers have CRP >10 mg/L from smoking alone 6, 3
Obesity, age, sex, and race can significantly affect baseline CRP levels 6, 1, 3
A single normal CRP does not rule out infection 3
Do not assume CRP >10 mg/L always indicates acute infection - it can be associated with chronic conditions, demographic factors, and lifestyle factors 6, 1
Relying solely on symptoms without confirming normalization of inflammatory markers may miss ongoing subclinical inflammation 1
Neutropenia, immunodeficiency, and NSAID use can affect CRP concentrations 3

The American Gastroenterological Association suggests screening systematically for common sources of infection, including urinary tract, soft tissue, and abdominal sources, in patients with elevated CRP 7
The American College of Rheumatology recommends considering bloodstream infection in patients with rigors, hypotension, or altered mental status, and elevated CRP 8

The American Heart Association recommends averaging two CRP measurements taken 2 weeks apart for stable cardiovascular risk assessment in patients with CRP <10 mg/L 9
The American Gastroenterological Association suggests that CRP >5 mg/L in symptomatic patients with inflammatory bowel disease indicates active endoscopic inflammation requiring treatment adjustment 7
The European League Against Rheumatism recommends referring patients with symptoms suggestive of giant cell arteritis or Takayasu arteritis and elevated CRP/ESR urgently to a specialist team for diagnostic work-up within 24 hours 8

CRP has 67% sensitivity and 77% specificity for moderate-to-severe endoscopic activity in ulcerative colitis, according to the American Gastroenterological Association 7
CRP has a 31.4% false-negative rate in high pretest probability scenarios for ulcerative colitis, meaning nearly one-third of patients with moderate-to-severe endoscopic activity will have normal CRP, as reported by the American Gastroenterological Association 7